Aurora A Recombinant Antibody, Biotin Conjugated, Clone: [1A7], Rabbit, Monoclonal

Product Overview

• Article Name: Aurora A Recombinant Antibody, Biotin Conjugated, Clone: [1A7], Rabbit, Monoclonal
• Biozol Catalog Number: BSS-BSM-52018R-BIOTIN
• Supplier Catalog Number: bsm-52018R-Biotin
• Alternative Catalog Number: BSS-BSM-52018R-BIOTIN-100
• Manufacturer: Bioss
• Host: Rabbit
• Category: Antikörper
• Application: IHC-Fr, IHC-P
• Species Reactivity: Human, Mouse, Rat
• Conjugation: Biotin
• Alternative Names: Aurora A Thr288, p-Aurora AT288, AIK, ARK-1, ARK1, AURA, AURKA, Aurora 2, Aurora A, Aurora A, Aurora Family Kinase 1, aurora kinase A, Aurora Related Kinase 1, Aurora-related kinase 1, Aurora/IPL1 Like Kinase, Aurora/IPL1 Related Kinase 1, Aurora/IPL1-related kinase 1, AURORA2, AYK1, BRAK, Breast Tumor Amplied Kinase, Breast tumor-amplied kinase, BTAK, hARK1, IAK, IPL1 Aurora Related Kinase 1, IPL1 Related Kinase, MGC34538, OTTHUMP00000031340, OTTHUMP00000031341, OTTHUMP00000031342, OTTHUMP00000031343, OTTHUMP00000031344, OTTHUMP00000031345, OTTHUMP00000166071, OTTHUMP00000166072, PPP1R47, Protein phosphatase 1, regulatory subunit 47, Serine/threonine kinase 15, Serine/threonine kinase 6, Serine/threonine kinase, Serine/threonine kinase, Serine/threonine-protein kinase 15, Serine/threonine-protein kinase 6, Serine/threonine-protein kinase aurora-A, STK15, STK6, STK6_HUMAN, STK7.

Product Description

Aurora A plays a role in cell cycle regulation during anaphase and/or telophase, in relation to the function of the centrosome/spindle pole region during chromosome segregation. Aurora A plays a key role during tumor development and progression and is overexpressed in many human cancers including breast, ovarian and colorectal. Aurora A is viewed as a potential target for anticancer drug treatment.

Product Properties

• Clonality: Monoclonal
• Concentration: Lot dependent
• Clone Designation: [1A7]
• NCBI: 6790
• UniProt: O14965
• Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
• Source: Recombinant human Aurora A protein, around C-terminal 250aa.
• Target: Aurora A

Application Notes

• Application Dilute: IHC-P(IF(ICC)), IHC-F((1:50-200))